200 mg
Trade Name
Fabhalta
Capsule, hard
Request Type
New Registration
Drug Type
NCE
Approval Date
SFDA Approved Use
Iptacopan is indicated as monotherapy in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia